Exor to buy 15% shareholding in Philips
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Subscribe To Our Newsletter & Stay Updated